Fusion proteins or chimeric (kī-ˈmir-ik) proteins (literally, made of parts from different sources) are proteins created through the joining of two or more genes that originally coded for separate proteins. 
This report contains market size and forecasts of Fusion Protein Therapy in Global, including the following market information:
Global Fusion Protein Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fusion Protein Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoglobulin (Ig) Fusion Protein Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fusion Protein Therapy include Roche, Abnova, Novus, Origene, Chimerigen, Peprotech, Prospec, Aboslute Antibody and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fusion Protein Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fusion Protein Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Type, 2021 (%)
Immunoglobulin (Ig) Fusion Protein
Parathyroid Hormone (PTH) Fusion Protein
Cytokines Recombinant Fusion Protein
Others
Global Fusion Protein Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fusion Protein Therapy Market Segment Percentages, by Application, 2021 (%)
Chimeric Protein Drugs
Biological Technology
Others
Global Fusion Protein Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fusion Protein Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fusion Protein Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fusion Protein Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abnova
Novus
Origene
Chimerigen
Peprotech
Prospec
Aboslute Antibody
Amgen
Abbvie
J & J
Bristol-Myers Squibb
Novartis
Merck
Alexion Pharmaceuticals
Takeda
Biogen
UCB
Eli Lilly and Company
AstraZeneca